Zusammenfassung
Wie kaum ein anderes Gebiet der Dermatologie machte die Therapie der Psoriasis in den letzten Jah ren eine explosionsartige Entwicklung durch. Diese Entwicklung betrifft einerseits die Verbesserung be stehender Therapieverfahren, z.B. die Einführung neuartiger Ultraviolettbestrahlungsmodalitäten und Kombinationstherapien, andererseits die Einfüh rung neuartiger Substanzgruppen für die innerliche und äußerliche Behandlung der Krankheit. Einige wesentliche Entwicklungen werden in der nachfol genden Aufstellung behandelt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Berth-Jones J, Chu A, Dodd W (1992) A multicentre, parallel-group comparison of calcipotriol ointment and short contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 127:266–277.
Collins P, Rogers S (1992) Bath water compared with oral delivery of 8 MOP PUVA therapy for chronic plaque psoriasis. Brit J Dermatol 127:392–395.
Cunliffe W, Berth-Jones J, Claudy A et al (1992) Com parative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Amer Acad Dermatol 26:736–743.
Diffey B, Farr P (1987) An appraisal of ultraviolet lamps used for the phototherapy of psoriasis. Brit J Dermatol 117:49–56.
Jegasothy BV, Ackerman CD, Todo S et al (1992) Tacrolimus (FK 506) — a new therapeutic agent for severe re calcitrant psoriasis. Arch Dermatol 128:781–785.
Karvonen J, Kokkonen E, Routsalainen E (1989) 311 nm UVB lamps in treatment of psoriasis with the Ingram regimen. Acta Derm Venereol (Stockh) 69:82–85.
Kemény L, Kenderessy AS, Olasz E et al (1994) The interleukin-8 receptor: a potential target for antipsoriatic therapy. Eur J Pharmacol 258:269–272.
Kerscher M, Volkenandt M, Plewig G, Lehmann P (1993) Combination phototherapy of psoriasis with calcipotriol and narrow band UVG-light. Lancet 342:923.
Kerscher M, Plewig G, Lehmann P (1993) Kombina tionstherapie der Psoriasis vulgaris mit einem Schmalspektrum UVB-Strahler (Philips TL 01, 311 nm) und Calcipotriol. Akt Dermatol 19:151–154.
Kerscher M, Plewig G, Lehmann P (1994) PUVA-BadTherapie mit 8-M0P zur Behandlung von palmoplantaren Dermatosen. Z Hautkr 69:110–112.
Kerscher M, Plewig G, Lehmann P (1994) PUVA-BadTherapie: Indikationen und praktische Durchführung. Hautarzt 45:126–139.
Kolb-Bachofen V, Fehsel K, Michel G, Ruzicka T (1994) Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet 344:139.
Kragballe K (1990) Combination of topical calcipotriol (MC 903) and UVB radiation for psoriasis vulgaris. Dermatol 181:211–214.
Kragballe K, Wildfang I (1989) Calcipotriol (MC 903), a novel vitamin D analogue stimulates terminal dif ferentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 282:164–167.
Kragballe K, Gjertsen B, Hoope D de et al (1991) Dou ble blind, right left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vul garis. Lancet 337:193–196.
Larkö O (1989) Treatment of psoriasis with a new UVB lamp. Acta Derm Venereol (Stockh) 69:357–359.
Lauerma AI, Maibach HI (1994) Topical FK 506 — clini cal potential or laboratory curiosity? Arch Derma tol 188:173–176.
Lowe N, Weingarten D, Bourgert T, Moy L (1986) PUVA therapy for psoriasis: comparison of oral and bath water delivery of 8-methoxypsoralen. J Am Acad Der matol 14:754–760.
Meingassner JG, Stütz A (1992) Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? J Invest Derma tol 98:851–855.
Parrish J, Jaenicke K (1981) Action spectrum for pho totherapy of psoriasis. J Invest Dermatol 76:359–362.
Peter RU, Ruzicka T, Donhauser G, Braun-Falco O (1990) Acrodermatitis continua suppurativa Hallopeau responds to low-dose treatment with Cyclosporin A. J Am Acad Dermatol 23:515–516.
Ruzicka T, Sommerburg C, Braun-Falco O et al (1990) Efficiency of acitretin in combination with ultra-violet B in the treatment of severe psoriasis. Arch Derma tol 126:482–486.
Ruzicka T, Arenberger P, Wagner S, Peter RU, Kemény L (1993) Psoriasis arthropathique. Ann Dermatol Venereol 120:5–13.
Schulz BS, Michel G, Wagner S et al (1993) Increased expression of epidermal interleukin-8 receptor in pso riasis. Downregulation by FK-506 in vitro. J Immu nol 151:4399–4406.
Speight EL, Farr PM (1994) Calcipotriol improves the response of psoriasis to PUVA. Br J Dermatol 130:79–82.
Storbeck K, Hölzle E, Lehmann P, Schürer N, Plewig G (1991) Die Wirksamkeit eines neuen Schmalspektrum-UVB-Strahlers (Philips TL 01/100 W, 311 nm) im Ver gleich zur konventionellen UVB-Phototherapie der Psoriasis. Z Hautkr 66:108–112.
Storbeck K, Lehmann P, Hölzle E, Schürer N, Plewig G (1993) Comparison of narrow band (311 nm) to broad band conventional UVB-phototherapy of psoriasis. J Am Acad Dermatol 28:227–231.
Weelden H van, Baart de la Faille H, Young E, Leun J van der (1988) A new development in UVB photo therapy of psoriasis. Br J Dermatol 119:11–19.
Weelden H van, Baart de la Faille H, Young E, Leun J van der (1990) Comparison of narrow-band UVB pho totherapy and PUVA photochemotherapy in the treat ment of psoriasis. Acta Derm Venereol (Stockh) 70:212–215.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ruzicka, T., Lehmann, P. (1995). Neue Entwicklungen in der Psoriasistherapie. In: Plewig, G., Korting, H.C. (eds) Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie, vol 14. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79156-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-79156-7_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79157-4
Online ISBN: 978-3-642-79156-7
eBook Packages: Springer Book Archive